DFTX vs LFST
DFTX: Definium is applying scientific rigor to psychedelics and empathogens to develop FDA-breakthrough-designated treatments for anxiety, depression, PTSD, and autism. LFST: LifeStance is a large-scale, tech-enabled outpatient mental health platform combining virtual and in-person care across 33 states with over 8,000 clinicians to address the $60+ billion underserved mental health market.
Side-by-side fundamentals
| Metric | DFTX | LFST | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $43.67 | $11.01 | |
| Market cap as of 2026-07-23 | $5.8B | $4.3B | |
| P/E as of 2026-07-23 | n/a | 184.08 | |
| PEG as of 2026-07-23 | -0.13 | n/a | |
| Net margin as of 2026-07-23 | n/a | +1.6% | |
| Operating margin as of 2026-07-23 | n/a | +3.0% | |
| ROE as of 2026-07-23 | -102.5% | +1.6% | LFST higher |
| ROA as of 2026-07-23 | -70.7% | +1.1% | LFST higher |
| Debt / equity as of 2026-07-23 | 0.15 | 0.19 | DFTX lower |
| Revenue growth (YoY) as of 2026-07-23 | n/a | -12.8% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +18.3% | |
| Beta as of 2026-07-23 | 2.29 | 1.19 | |
| 1-year return as of 2026-07-22 close | +353.1% | +174.6% | DFTX higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.